Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05131308 · ClinicalTrials.gov registry record
Multimodality Evaluation of LAA Leaks Arising After Incomplete LAAC: Insights From the LAA-Leak Registry
A clinical trial, sponsored by Kansas City Heart Rhythm Research Foundation.
- Completed
- Registry status
- 160
- Enrollment target
NCT05131308: Completed study, sponsored by Kansas City Heart Rhythm Research Foundation.
NCT05131308 is a clinical trial that has completed, run by Kansas City Heart Rhythm Research Foundation. The registered enrollment target is 160 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05131308 has completed, sponsored by Kansas City Heart Rhythm Research Foundation.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
Study Summary
Closure of peri-device leaks (PDL) after incomplete LAAC have shown early feasibility, however no comparison study of all the leak closure modalities exists. Therefore, this is an attempt to report the first 3-way observational comparison study to date, with results in 160 total patients in 3 arms including detachable embolization coils, vascular plugs/septal occluders and Radiofrequency ablation.
Primary Outcome
Size of leak in mm on TEE after leak closure procedure, immediately at the end of the procedure and at 1 year follow-up
Interventions
- OTHER leak closure with either detachable embolization coils, vascular plugs/CSO, or RFA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2015-01-11 |
| Est. Completion | 2021-06-08 |
What the finished NCT05131308 record still lists
NCT05131308 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which leak closure with either detachable embolization coils, vascular plugs/CSO, or RFA is the first listed.
NCT05131308 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05131308 about?
NCT05131308 is a clinical study titled "Multimodality Evaluation of LAA Leaks Arising After Incomplete LAAC: Insights From the LAA-Leak Registry". Closure of peri-device leaks (PDL) after incomplete LAAC have shown early feasibility, however no comparison study of all the leak closure modalities exists. Therefore, this is an attempt to report the first 3-way observational comparison study to date, with results in 160 total patients in 3 arms i...
What is the current status of trial NCT05131308?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2015-01-11. Estimated completion is 2021-06-08.
What interventions are being tested in trial NCT05131308?
The interventions under investigation include: leak closure with either detachable embolization coils, vascular plugs/CSO, or RFA (OTHER).
Who is sponsoring clinical trial NCT05131308?
This trial is sponsored by Kansas City Heart Rhythm Research Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI